BRCA2 and breast cancer: Sanger sequencing of the coding sequences and exon–intron junctions of BRCA1 and BRCA2 on DNA from the blood samples of the patients who donated their breast cancer tissue for PDTX, had confirmed the absence of pathogenic germline mutations in both PDTX models (Tables S3 and S4).